Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

A. Alvarez-Larran, A. Pereira, P. Guglielmelli, J. C. Hernandez-Boluda, E. Arellano-Rodrigo, F. Ferrer-Marin, A. Samah, M. Griesshammer, A. Kerguelen, B. Andreasson, C. Burgaleta, J. Schwarz, V. Garcia-Gutierrez, R. Ayala, P. Barba, M. T. Gomez-Casares, C. Paoli, B. Drexler, S. Zweegman, M. F. McMullin, J. Samuelsson, C. Harrison, F. Cervantes, A. M. Vannucchi, C. Besses

Open source

DOI
10.3324/haematol.2016.146654
Published
2016-05-12
Container
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2016.146654,
  title = {Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation},
  author = {A. Alvarez-Larran and A. Pereira and P. Guglielmelli and J. C. Hernandez-Boluda and E. Arellano-Rodrigo and F. Ferrer-Marin and A. Samah and M. Griesshammer and A. Kerguelen and B. Andreasson and C. Burgaleta and J. Schwarz and V. Garcia-Gutierrez and R. Ayala and P. Barba and M. T. Gomez-Casares and C. Paoli and B. Drexler and S. Zweegman and M. F. McMullin and J. Samuelsson and C. Harrison and F. Cervantes and A. M. Vannucchi and C. Besses},
  year = {2016},
  journal = {Haematologica},
  doi = {10.3324/haematol.2016.146654},
  url = {https://doi.org/10.3324/haematol.2016.146654}
}

RIS

TY  - JOUR
TI  - Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation
AU  - A. Alvarez-Larran
AU  - A. Pereira
AU  - P. Guglielmelli
AU  - J. C. Hernandez-Boluda
AU  - E. Arellano-Rodrigo
AU  - F. Ferrer-Marin
AU  - A. Samah
AU  - M. Griesshammer
AU  - A. Kerguelen
AU  - B. Andreasson
AU  - C. Burgaleta
AU  - J. Schwarz
AU  - V. Garcia-Gutierrez
AU  - R. Ayala
AU  - P. Barba
AU  - M. T. Gomez-Casares
AU  - C. Paoli
AU  - B. Drexler
AU  - S. Zweegman
AU  - M. F. McMullin
AU  - J. Samuelsson
AU  - C. Harrison
AU  - F. Cervantes
AU  - A. M. Vannucchi
AU  - C. Besses
PY  - 2016
JO  - Haematologica
DO  - 10.3324/haematol.2016.146654
UR  - https://doi.org/10.3324/haematol.2016.146654
ER  - 

APA

Alvarez-Larran, A., Pereira, A., Guglielmelli, P., Hernandez-Boluda, J. C., Arellano-Rodrigo, E., Ferrer-Marin, F., Samah, A., Griesshammer, M., Kerguelen, A., Andreasson, B., Burgaleta, C., Schwarz, J., Garcia-Gutierrez, V., Ayala, R., Barba, P., Gomez-Casares, M. T., Paoli, C., Drexler, B., Zweegman, S., McMullin, M. F., Samuelsson, J., Harrison, C., Cervantes, F., Vannucchi, A. M., & Besses, C. (2016). Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation. Haematologica. https://doi.org/10.3324/haematol.2016.146654

Source records